Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 937–960 of 25,190 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: PRE Clear all

Conditions: Type 1 Diabetes
Interventions: Alprazolam, control group; Drug · Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Follicular Lymphoma, Diffuse Large B-Cell Lymphoma
Interventions: Obinutuzumab, Pinatuzumab Vedotin, Polatuzumab Vedotin, Rituximab; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 26
States / cities: Los Angeles, California • Stanford, California • Denver, Colorado + 21 more

Conditions: Primary Hyperparathyroidism, Hypercalcemia
Interventions: Calcitonin; Drug
Lead sponsor: Joseph Sferra; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Toledo, Ohio

Conditions: Posttraumatic Stress Disorder, Tobacco Dependence
Interventions: Tobacco treatment, Health Education; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Congenital Heart Disease in Children, Inflammatory Response
Interventions: Methylprednisolone, Isotonic saline; Drug
Lead sponsor: Kevin Hill; Other
Eligibility: Up to 12 Months
Enrollment: 1,263 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 23
States / cities: Los Angeles, California • Aurora, Colorado • Gainesville, Florida + 20 more

Conditions: Mastectomy
Interventions: Discharge timing; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 19 Years to 80 Years · Female only
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Intracerebral Hemorrhage
Interventions: Viz ICH VOLUME; Device
Lead sponsor: Viz.ai, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 5
States / cities: Englewood, Colorado • New York, New York • Charlotte, North Carolina + 2 more

Conditions: Pre-term Birth
Interventions: Not listed
Lead sponsor: Hologic, Inc.; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 1,210 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 16
States / cities: Birmingham, Alabama • San Diego, California • Newark, Delaware + 13 more

Conditions: Diagnostic Errors
Interventions: ADEPT Program; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 7,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: San Francisco, California • Boston, Massachusetts

Conditions: Polycystic Ovary Syndrome
Interventions: Metformin; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Hypoxemia
Interventions: Capnography; Diagnostic Test
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 263 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Preterm Labor
Interventions: Not listed
Lead sponsor: CAMC Health System; Other
Eligibility: 14 Years to 45 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Development Delay, Social Skills, Parents
Interventions: Parent Training, Video Modeling; Behavioral
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 3 Years and older
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Focal Epilepsy, Drug-resistant Focal Epilepsy
Interventions: NeuroPace RNS System; Device
Lead sponsor: NeuroPace; Industry
Eligibility: 13 Years to 19 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Waltham, Massachusetts

Conditions: Dehydration, Mood
Interventions: Increase water consumption, Maintain adequate water consumption; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 217 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Cancer, Immune-related Adverse Event
Interventions: Medical chart review; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Obese, Obesity
Interventions: HM15275, Placebo of HM15275; Drug
Lead sponsor: Hanmi Pharmaceutical Company Limited; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 14
States / cities: Chula Vista, California • Oak Lawn, Illinois • Ames, Iowa + 10 more

Conditions: Surgery, Anesthesia, Pain
Interventions: General Anesthesia, Deep Sedation; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Colorectal Cancer
Interventions: Generic message, Tailored message; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 50 Years to 75 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Acute Kidney Injury
Interventions: Early RASi restart strategy, Usual Care; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pediatric Post-tonsillectomy Pain
Interventions: Dexamethasone, Placebo; Drug
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 4 Years to 17 Years
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Esophageal Cancer, Extragonadal Germ Cell Tumor, Gastric Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer
Interventions: lapatinib, paclitaxel; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: PCOS, Polycystic Ovary Syndrome
Interventions: Micronized progesterone, Placebo, Flutamide, Estradiol patch; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 30 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Growth Disorder, Growth Hormone Deficiency in Children
Interventions: No treatment given; Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 4 Years to 13 Years
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 24
States / cities: Phoenix, Arizona • Centennial, Colorado • Wilmington, Delaware + 20 more

Search by objective public record fields.

Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2

A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity

Tobacco Treatment as Augmentation for Cognitive Processing Therapy for PTSD

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

RCT Implant Based Breast Reconstruction

ADVANCE- Automated Detection and Volumetric Assessment of ICH

fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

Achieving Diagnostic Excellence Through Prevention and Teamwork

Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)

Does Capnography Prevent Hypoxemia During Endoscopic Retrograde Cholangiopancreatography and Endoscopic Ultrasound?

Phospholipase A2 Producing Bacteria and Pre-Term Labor

Home-Based Social Skills Intervention for Young Children With Developmental Delays

RNS System for Drug-Resistant Focal Epilepsy in Adolescents: A Real-World Study

The Impact of Adequate Water Intake on Exercise Performance and Mood in Women and Men

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

Intravenous Sedation Versus General Anesthesia in Patients Undergoing Minor Gynecologic Surgery

Tailored Messaging for CRC Screening

A Prompt REstart Study of Renin-Angiotensin System Inhibitors After Acute Kidney Injury

Dexamethasone and Post-tonsillectomy Pain in Children

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion

Validation of Two Measures for Growth Hormone Deficiency in Children, the Treatment Related Impact Measure of Childhood Growth Hormone Deficiency (TRIM-CGHD) and the Treatment Burden Measure of Childhood Growth Hormone Deficiency (TB-CGHD)